S
CTKB icon

SignatureFD’s Cytek Biosciences CTKB Stock Holding History

SignatureFD’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.91K Hold
438
– – ﹤0.01% 3067
2025
Q4 		$2.21K Hold
438
– – ﹤0.01% 2939
2025
Q3 		$1.52K Buy
438
+34
+8% +$128 ﹤0.01% 3010
2025
Q2 		$1.37K Buy
404
+360
+818% +$1.2K ﹤0.01% 2953
2025
Q1 		$176 Sell
44
-69
-61% -$358 ﹤0.01% 3249
2024
Q4 		$733 Hold
113
– – ﹤0.01% 3083
2024
Q3 		$626 Buy
+113
New +$641 ﹤0.01% 3065

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SignatureFD's CTKB Position: Q1 2026 in Review

SignatureFD held its Cytek Biosciences (CTKB) position steady in Q1 2026 at 438 shares worth $1.91K. The position accounts for ﹤0.01% of the portfolio, ranked #3067.

SignatureFD first reported a position in CTKB in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.21K in Q4 2025. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

  • SignatureFD held 438 shares of Cytek Biosciences worth $1.91K as of Q1 2026.
  • SignatureFD left its Cytek Biosciences share count unchanged in Q1 2026.
  • Cytek Biosciences made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #3067 holding.
  • SignatureFD first reported a position in Cytek Biosciences in Q3 2024 and has held it in 7 quarters since.
  • SignatureFD's Cytek Biosciences position peaked at $2.21K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.